Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis
Public ClinicalTrials.gov record NCT02376790. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter Double-Blind, Randomized Controlled Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects With Psoriatic Arthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to learn more about the role of etanercept alone or in combination with methotrexate on disease activity in adults with psoriatic arthritis.
Study identification
- NCT ID
- NCT02376790
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 851 participants
Conditions and interventions
Conditions
Interventions
- Etanercept Drug
- Methotrexate Drug
- Placebo to Etanercept Drug
- Placebo to Methotrexate Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2, 2015
- Primary completion
- Jan 8, 2018
- Completion
- Jul 5, 2018
- Last update posted
- Sep 20, 2022
2015 – 2018
United States locations
- U.S. sites
- 55
- U.S. states
- 26
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Tuscaloosa | Alabama | 35406 | — |
| Research Site | Glendale | Arizona | 85306 | — |
| Research Site | Mesa | Arizona | 85202 | — |
| Research Site | Scottsdale | Arizona | 85258 | — |
| Research Site | Little Rock | Arkansas | 72205 | — |
| Research Site | Escondido | California | 92025 | — |
| Research Site | Hemet | California | 92543 | — |
| Research Site | Los Angeles | California | 90095 | — |
| Research Site | Mather | California | 95655 | — |
| Research Site | Palm Desert | California | 92260 | — |
| Research Site | San Francisco | California | 94143 | — |
| Research Site | Santa Monica | California | 90404 | — |
| Research Site | Thousand Oaks | California | 91360 | — |
| Research Site | Tustin | California | 92780 | — |
| Research Site | Aventura | Florida | 33180 | — |
| Research Site | Clearwater | Florida | 33765 | — |
| Research Site | Kissimmee | Florida | 34741 | — |
| Research Site | Ocoee | Florida | 34761 | — |
| Research Site | Tampa | Florida | 33609 | — |
| Research Site | Tampa | Florida | 33613 | — |
| Research Site | Zephyrhills | Florida | 33542 | — |
| Research Site | Meridian | Idaho | 83642 | — |
| Research Site | Chicago | Illinois | 60611 | — |
| Research Site | Springfield | Illinois | 62703 | — |
| Research Site | Bowling Green | Kentucky | 42101 | — |
| Research Site | Paducah | Kentucky | 42003 | — |
| Research Site | Frederick | Maryland | 21702 | — |
| Research Site | Hagerstown | Maryland | 21740 | — |
| Research Site | Wheaton | Maryland | 20902 | — |
| Research Site | Worcester | Massachusetts | 01605 | — |
| Research Site | Lansing | Michigan | 48910 | — |
| Research Site | Lansing | Michigan | 48917 | — |
| Research Site | Saint Clair Shores | Michigan | 48081 | — |
| Research Site | Rochester | Minnesota | 55905 | — |
| Research Site | Las Vegas | Nevada | 89128 | — |
| Research Site | Lebanon | New Hampshire | 03756 | — |
| Research Site | Clifton | New Jersey | 07012 | — |
| Research Site | Freehold | New Jersey | 07728 | — |
| Research Site | Albuquerque | New Mexico | 87102 | — |
| Research Site | New York | New York | 10016 | — |
| Research Site | Rochester | New York | 14642 | — |
| Research Site | Asheville | North Carolina | 28803 | — |
| Research Site | Charlotte | North Carolina | 28204 | — |
| Research Site | Cleveland | Ohio | 44109 | — |
| Research Site | Oklahoma City | Oklahoma | 73103 | — |
| Research Site | Duncansville | Pennsylvania | 16635 | — |
| Research Site | Wyomissing | Pennsylvania | 19610 | — |
| Research Site | Charleston | South Carolina | 29406 | — |
| Research Site | Rapid City | South Dakota | 57701 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | San Antonio | Texas | 78232 | — |
| Research Site | Chesapeake | Virginia | 23320 | — |
| Research Site | Danville | Virginia | 24541 | — |
| Research Site | Roanoke | Virginia | 24016 | — |
| Research Site | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 83 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02376790, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 20, 2022 · Synced Sep 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02376790 live on ClinicalTrials.gov.